Vasacare Limited 31/03/2025 iXBRL

Company registration number: 06136040

Vasacare Limited

Unaudited abridged financial statements

31 March 2025

Vasacare Limited

Contents

Directors and other information

Directors report

Accountants report

Abridged statement of comprehensive income

Abridged statement of financial position

Statement of changes in equity

Notes to the financial statements

Vasacare Limited

Directors and other information


	Directors	Dominic Dodd
		Caroline Dodd


	Secretary	Caroline Dodd


	Company number	06136040


	Registered office	29 Whirlow Park Road
		Sheffield
		West Yorkshire
		S11 9NN


	Business address	29 Whirlow Park Road
		Sheffield
		West Yorkshire
		S11 9NN


	Accountants	T R Dixon & Co Ltd
		Chartered Certified Accountants
		Statutory Auditors
		Bermuda House
		1a Dinsdale Place
		Newcastle upon Tyne
		NE2 1BD

Vasacare Limited

Directors report

Year ended 31 March 2025

The directors present their report and the unaudited financial statements of the company for the year ended 31 March 2025.

Directors

The directors who served the company during the year were as follows:

Dominic Dodd

Caroline Dodd

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 14 November 2025 and signed on behalf of the board by:

Dominic Dodd

Director

Vasacare Limited

Report to the board of directors on the preparation of the

unaudited statutory financial statements of Vasacare Limited

Year ended 31 March 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Vasacare Limited for the year ended 31 March 2025 which comprise the abridged statement of comprehensive income, abridged statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements.

This report is made solely to the board of directors of Vasacare Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Vasacare Limited and state those matters that we have agreed to state to the board of directors of Vasacare Limited as a body, in this report in accordance with the ACCA to the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Vasacare Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Vasacare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Vasacare Limited. You consider that Vasacare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Vasacare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

T R Dixon & Co Ltd

Chartered Certified Accountants

Statutory Auditors

Bermuda House

1a Dinsdale Place

Newcastle upon Tyne

NE2 1BD

14 November 2025

Vasacare Limited

Abridged statement of comprehensive income

Year ended 31 March 2025

		2025	2024
	Note	£	£

Gross profit		320,462	482,651

Administrative expenses		( 164,666)	( 164,596)
		_______	_______
Operating profit		155,796	318,055

Interest payable and similar expenses		( 4,691)	-
		_______	_______
Profit before taxation	5	151,105	318,055

Tax on profit		( 37,648)	( 79,830)
		_______	_______
Profit for the financial year and total comprehensive income		113,457	238,225
		_______	_______

All the activities of the company are from continuing operations.

Vasacare Limited

Abridged statement of financial position

31 March 2025

		2025		2024
	Note	£	£	£	£

Fixed assets
Intangible assets	6	-		-
Tangible assets	7	5,671		6,095
		_______		_______
			5,671		6,095

Current assets
Debtors		12,422		62,879
Cash at bank and in hand		345,617		440,266
		_______		_______
		358,039		503,145
Creditors: amounts falling due
within one year		( 43,516)		( 102,503)
		_______		_______
Net current assets			314,523		400,642
			_______		_______
Total assets less current liabilities			320,194		406,737

			_______		_______
Net assets			320,194		406,737
			_______		_______

Capital and reserves
Called up share capital			2		2
Profit and loss account			320,192		406,735
			_______		_______
Shareholders funds			320,194		406,737
			_______		_______

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the current year ending 31 March 2025 in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements were approved by the board of directors and authorised for issue on 14 November 2025 , and are signed on behalf of the board by:

Dominic Dodd

Director

Company registration number: 06136040

Vasacare Limited

Statement of changes in equity

Year ended 31 March 2025

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 April 2023	2	368,510	368,512

Profit for the year		238,225	238,225
	_______	_______	_______
Total comprehensive income for the year	-	238,225	238,225

Dividends paid and payable		( 200,000)	( 200,000)
	_______	_______	_______
Total investments by and distributions to owners	-	( 200,000)	( 200,000)

	_______	_______	_______
At 31 March 2024 and 1 April 2024	2	406,735	406,737

Profit for the year		113,457	113,457
	_______	_______	_______
Total comprehensive income for the year	-	113,457	113,457

Dividends paid and payable		( 200,000)	( 200,000)
	_______	_______	_______
Total investments by and distributions to owners	-	( 200,000)	( 200,000)

	_______	_______	_______
At 31 March 2025	2	320,192	320,194
	_______	_______	_______

Vasacare Limited

Notes to the financial statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in England & Wales. The address of the registered office is 29 Whirlow Park Road, Sheffield, West Yorkshire, S11 9NN.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

Goodwill 10 %

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:


Plant and machinery	-	15 %	straight line

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 2 (2024: 2).

5. Profit before taxation

Profit before taxation is stated after charging/(crediting):

	2025	2024
	£	£
Depreciation of tangible assets	1,662	2,365
	_______	_______

6. Intangible assets


		£
	Cost
	At 1 April 2024 and 31 March 2025	30,000
		_______
	Amortisation
	At 1 April 2024 and 31 March 2025	30,000
		_______
	Carrying amount
	At 31 March 2025	-
		_______
	At 31 March 2024	-
		_______

7. Tangible assets


		£
	Cost
	At 1 April 2024	20,749
	Additions	1,238
		_______
	At 31 March 2025	21,987
		_______
	Depreciation
	At 1 April 2024	14,654
	Charge for the year	1,662
		_______
	At 31 March 2025	16,316
		_______
	Carrying amount
	At 31 March 2025	5,671
		_______
	At 31 March 2024	6,095
		_______

8. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

2025
		Balance brought forward	Advances /(credits) to the directors	Amounts repaid	Balance o/standing
		£	£	£	£
	Dominic Dodd	( 21,110)	226,797	( 209,695)	( 4,008)
		_______	_______	_______	_______

2024
		Balance brought forward	Advances /(credits) to the directors	Amounts repaid	Balance o/standing
		£	£	£	£
	Dominic Dodd	( 35,474)	229,146	( 212,824)	(19,152)
		_______	_______	_______	_______

9. Related party transactions

During the year the company entered into the following transactions with related parties:

	Transaction value		Balance owed by/(owed to)
	2025	2024	2025	2024
	£	£	£	£
Vasacare Holdings Limited	1,830	3,000	4,830	3,000
	_______	_______	_______	_______